Condensed Consolidated Statement of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Revenue
Patient service revenue, net	$ 1,470,550	$ 1,111,090	$ 2,984,926	$ 2,448,030
Consulting and event revenue	71,864	50,420	159,519	50,420
Product revenue	168,206		350,869
Total revenue	1,710,620	1,161,510	3,495,314	2,498,450
Operating Expenses and costs
Practice salaries and benefits	903,032	555,086	1,566,969	1,320,207
Other practice operating expenses	511,004	521,022	1,241,788	1,084,713
Medicare shared savings expenses	197,463	64,236	408,970	64,236
Cost of product revenue	159,998		328,594
Selling, general and administrative expenses	1,147,478	646,309	2,513,615	1,157,285
Depreciation and amortization	206,469	24,874	418,127	49,660
Total Operating Expenses and Costs	3,125,444	1,811,527	6,478,063	3,676,101
Loss from operations	(1,414,824)	(650,017)	(2,982,749)	(1,177,651)
Other Income (Expenses)
Gain (loss) on extinguishment of debt	632,826	(428,435)	(4,957,168)	(896,372)
Change in fair value of debt		(155,667)	(19,246)	(119,702)
Amortization of original issue and debt discounts on notes payable and convertible notes		(172,951)		(465,114)
Change in fair value of derivative financial instruments		(13,672)		726,683
Change in fair value of contingent acquisition consideration	274,611	(38,688)	(361,089)	(45,309)
Interest income (expense)	1,623	(58,418)	(8,965)	(120,599)
Total other income (expenses)	909,060	(867,831)	(5,346,468)	(920,413)
Net loss before provision for income taxes	(505,764)	(1,517,848)	(8,329,217)	(2,098,064)
Provision for income taxes
Net loss	(505,764)	(1,517,848)	(8,329,217)	(2,098,064)
Deemed dividend - amortization of beneficial conversion feature and down round adjustment to warrants	(88,393)		(176,786)
Net loss to common stockholders	$ (594,157)	$ (1,517,848)	$ (8,506,003)	$ (2,098,064)
Basic (in Dollars per share)	$ 0.00	$ (0.01)	$ (0.04)	$ (0.02)
Fully diluted (in Dollars per share)	$ 0.00	$ (0.01)	$ (0.04)	$ (0.02)
Basic (in Shares)	228,007,727	125,535,787	220,823,912	118,881,613
Fully diluted (in Shares)	228,007,727	125,535,787	220,823,912	118,881,613